Aegerion Pharmaceuticals Limited LONDON


Founded in 2012, Aegerion Pharmaceuticals, classified under reg no. 08114919 is an active company. Currently registered at C/o Corporation Service Company (uk) Limited 5 Churchill Place E14 5HU, London the company has been in the business for twelve years. Its financial year was closed on 31st December and its latest financial statement was filed on 2022-12-31.

At the moment there are 3 directors in the the company, namely Andrew D., Matthew W. and Ailish H.. In addition one secretary - Matthew W. - is with the firm. At the moment there are several former directors listed by the company. In addition, the company lists several former secretaries. The full list of both former directors and former secretaries might be found in the box below.

Aegerion Pharmaceuticals Limited Address / Contact

Office Address C/o Corporation Service Company (uk) Limited 5 Churchill Place
Office Address2 10th Floor
Town London
Post code E14 5HU
Country of origin United Kingdom

Company Information / Profile

Registration Number 08114919
Date of Incorporation Thu, 21st Jun 2012
Industry Wholesale of pharmaceutical goods
End of financial Year 31st December
Company age 12 years old
Account next due date Mon, 30th Sep 2024 (145 days left)
Account last made up date Sat, 31st Dec 2022
Next confirmation statement due date Fri, 5th Jul 2024 (2024-07-05)
Last confirmation statement dated Wed, 21st Jun 2023

Company staff

Andrew D.

Position: Director

Appointed: 26 May 2023

Matthew W.

Position: Secretary

Appointed: 26 May 2023

Matthew W.

Position: Director

Appointed: 26 May 2023

Ailish H.

Position: Director

Appointed: 26 May 2023

Corporation Service Company (uk) Limited

Position: Corporate Secretary

Appointed: 04 January 2021

Resigned: 01 August 2023

Ailish H.

Position: Secretary

Appointed: 24 September 2019

Resigned: 26 May 2023

David G.

Position: Director

Appointed: 24 September 2019

Resigned: 13 July 2023

John M.

Position: Director

Appointed: 24 September 2019

Resigned: 26 May 2023

Benjamin H.

Position: Director

Appointed: 18 December 2017

Resigned: 24 September 2019

Barbara C.

Position: Director

Appointed: 01 October 2017

Resigned: 24 September 2019

Janet K.

Position: Director

Appointed: 15 July 2016

Resigned: 18 December 2017

David A.

Position: Director

Appointed: 15 July 2016

Resigned: 31 March 2017

Julian T.

Position: Director

Appointed: 15 July 2016

Resigned: 01 October 2017

David S.

Position: Director

Appointed: 15 July 2016

Resigned: 01 October 2017

Julian T.

Position: Director

Appointed: 01 May 2014

Resigned: 11 December 2014

Benjamin H.

Position: Director

Appointed: 01 May 2014

Resigned: 15 July 2016

Massimo B.

Position: Director

Appointed: 21 February 2013

Resigned: 16 January 2015

Sisec Limited

Position: Corporate Secretary

Appointed: 21 June 2012

Resigned: 24 September 2019

Mark R.

Position: Director

Appointed: 21 June 2012

Resigned: 21 February 2013

Anne C.

Position: Director

Appointed: 21 June 2012

Resigned: 01 May 2014

Anne C.

Position: Secretary

Appointed: 21 June 2012

Resigned: 01 May 2014

Jean-Yves B.

Position: Director

Appointed: 21 June 2012

Resigned: 15 July 2016

People with significant control

The list of PSCs who own or have control over the company is made up of 3 names. As we discovered, there is Amryt Pharma Holdings Limited from London, England. The abovementioned PSC is categorised as "a private limited company", has 75,01-100% voting rights and has 75,01-100% shares. The abovementioned PSC has 75,01-100% voting rights and has 75,01-100% shares. The second entity in the persons with significant control register is Novelion Therapeutics Inc. that entered Vancouver, Canada as the official address. This PSC has a legal form of "a corporation", owns 75,01-100% shares, has 75,01-100% voting rights. This PSC owns 75,01-100% shares and has 75,01-100% voting rights. Then there is Aegerion Pharmaceuticals, Inc., who also meets the Companies House requirements to be listed as a person with significant control. This PSC has a legal form of "a corporation", owns 75,01-100% shares, has 75,01-100% voting rights. This PSC , owns 75,01-100% shares and has 75,01-100% voting rights.

Amryt Pharma Holdings Limited

Dept 920a 196 High Road, London, N22 8HH, England

Legal authority Companies Act 2006
Legal form Private Limited Company
Country registered United Kingdom (England And Wales)
Place registered Companies House
Registration number 05316808
Notified on 24 September 2019
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Novelion Therapeutics Inc.

887 Great Northern Way, Vancouver, British Columbia, Canada

Legal authority Canadian
Legal form Corporation
Country registered British Columbia
Place registered British Colombia (Bc Registry Services)
Registration number Bc0698743
Notified on 29 November 2016
Ceased on 24 September 2019
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Aegerion Pharmaceuticals, Inc.

101 Main Street, Suite 1850, Cambridge, MA 02142, Usa

Legal authority State Of Delaware
Legal form Corporation
Country registered Delaware
Place registered Delaware (Division Of Corporations)
Registration number 3922075
Notified on 6 April 2016
Ceased on 29 November 2016
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Company filings

Filing category
Accounts Address Annual return Capital Confirmation statement Gazette Incorporation Mortgage Officers Persons with significant control Resolution
Full accounts data made up to 2022-12-31
filed on: 23rd, September 2023
Free Download (28 pages)

Company search